Codeine is not available over the counter in the United States in the traditional sense, but a handful of states do allow pharmacists to sell low-dose codeine cough syrup without a prescription. The rules vary dramatically depending on where you live, and many countries that once sold codeine freely have tightened access in recent years.
How Codeine Is Classified in the U.S.
Under federal law, codeine falls into different controlled substance categories depending on the dose and what it’s combined with. Combination products containing no more than 200 milligrams of codeine per 100 milliliters (or per 100 grams), mixed with at least one other active ingredient, are classified as Schedule V, the lowest level of controlled substance. Higher-dose codeine products, those with up to 90 milligrams per dose combined with another active ingredient, sit in Schedule III and always require a prescription.
Schedule V status doesn’t automatically mean you can buy it off the shelf. Federal law permits pharmacists to dispense Schedule V products without a prescription, but individual states can impose stricter rules. Most states have done exactly that, requiring a prescription for any codeine product regardless of dose.
States Where You Can Buy It Without a Prescription
A small number of states, including North Carolina, Florida, Oklahoma, and Iowa, allow pharmacists to dispense low-dose codeine cough syrup behind the counter without a prescription. Even in these states, the purchase isn’t as simple as picking up ibuprofen. You typically need to ask the pharmacist directly, show identification, sign a log book, and buy only a limited quantity. The pharmacist also has discretion to refuse the sale.
If you’re in one of these states and considering this option, call the pharmacy ahead of time. Policies vary between pharmacy chains, and some corporate policies prohibit the sale even where state law allows it.
Codeine Access in Canada and the UK
Canada allows the sale of low-dose codeine products (8 milligrams or less per tablet, 20 milligrams or less per 30 milliliters of liquid) directly from a pharmacist without a prescription. These are typically combination products that pair codeine with acetaminophen or ibuprofen and are used for mild to moderate pain or as a cough suppressant. You won’t find them on open shelves; you need to speak with the pharmacist at the dispensary counter.
The United Kingdom takes a similar approach. Codeine-containing painkillers are available as “pharmacy medicines,” meaning a pharmacist can sell them without a prescription but must be involved in the transaction. Pack sizes are limited to 32 tablets. Anything larger requires a prescription. Products like co-codamol (codeine combined with paracetamol) are widely available this way across the UK.
Australia Pulled Codeine Off Shelves Entirely
Australia used to allow over-the-counter codeine sales, but the Therapeutic Goods Administration reclassified all codeine products as prescription-only in February 2018. The decision was driven by mounting evidence of harm from long-term, unsupervised use of combination products. People taking more than the recommended dose of codeine paired with paracetamol risked liver damage, while overuse of codeine-ibuprofen combinations was linked to serious internal bleeding, kidney failure, and heart attack. The risks came not just from the codeine itself but from the other ingredients people inadvertently consumed in large quantities while chasing pain relief or managing dependence.
Why Low-Dose Codeine May Not Be Worth It
One reason regulators have been comfortable restricting codeine is that low-dose formulations don’t offer much advantage over simpler alternatives. In a randomized trial comparing 400 milligrams of ibuprofen against a combination of acetaminophen with 60 milligrams of codeine, both provided nearly identical pain relief over 24 hours, with equivalent satisfaction scores. The key difference: 72% of patients taking the codeine combination experienced side effects compared to 52% taking ibuprofen alone. Those side effects commonly include constipation, nausea, drowsiness, and dry mouth.
For mild to moderate pain, over-the-counter ibuprofen or acetaminophen (or the two taken together on a rotating schedule) often works just as well without the added risks that come with an opioid.
Genetic Differences Change How Codeine Works
Codeine is actually a prodrug. It doesn’t relieve pain on its own. Your liver has to convert it into morphine, and how efficiently that happens depends on your genetics. Roughly 5 to 10 percent of people are “poor metabolizers” who convert very little codeine into morphine, meaning the drug barely works for them at all. On the other end, about 1 to 2 percent of people are “ultra-rapid metabolizers” who convert codeine into morphine much faster and in larger amounts than normal. For these individuals, even a standard dose can produce dangerously high morphine levels, leading to severe sedation or life-threatening breathing problems.
This genetic variability is one reason codeine is contraindicated for all children under 12. Several cases of life-threatening respiratory depression and death in children were linked to ultra-rapid metabolism, particularly after tonsil and adenoid surgeries. Adolescents aged 12 to 18 who are obese, have sleep apnea, or have lung conditions are also considered high risk. Breastfeeding mothers who are ultra-rapid metabolizers can pass dangerous levels of morphine to their infants through breast milk.
Risks of Regular Use
Even at low doses, codeine carries a real risk of physical dependence. People who use codeine-containing products daily for more than a few days can develop tolerance, needing more of the product to get the same effect. Because over-the-counter codeine products are always combined with another painkiller, escalating the dose means consuming increasing amounts of acetaminophen or ibuprofen. This is where the most serious organ damage occurs: liver toxicity from paracetamol and gastrointestinal bleeding or kidney failure from ibuprofen, sometimes before the person realizes they have a problem.
This pattern of harm from the “other ingredient” in combination products was a central factor behind Australia’s decision to require prescriptions and behind ongoing debates in Canada and the UK about whether pharmacy-level access is safe enough.